A week after the Centre banned the manufacturing, sale and distribution of 328 fixed dose combination (FDCNSE -1.81 %) drugs, Indian pharma major WockhardtNSE 7.53 % Friday moved the Delhi High Court against the Health Ministry's decision. The petition by Wockhardt was mentioned before a bench of Justices S Ravindra Bhat and A K Chawla, which allowed it to be listed for hearing today.